Review: PrP 106-126 - 25 years after

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Prion diseases are complex neurodegenerative disorders with unresolved pathogenesis.
• The human prion protein (PrP) and its amyloid forms are implicated in disease.
• Early 1990s research identified key mechanisms in protein-misfolding diseases.

Purpose of the Study:

• To review the impact of the PrP106-126 peptide on prion disease research.
• To analyze advances in understanding prion disease pathogenesis and neurotoxicity.
• To discuss evolving therapeutic perspectives in prion disease over 25 years.

Main Methods:

• Synthesis of a peptide homologous to PrP residues 106-126.
• Investigating the neurotoxic mechanisms of PrP106-126.
• Reviewing subsequent discoveries in prion and neurodegenerative disease research.

Main Results:

• PrP106-126 provided a tractable model for studying prion disease pathogenesis and neurotoxicity.
• Established the role of amyloid in protein-misfolding neurodegenerative disorders.
• Highlighted the involvement of programmed cell death in central nervous system diseases.

Conclusions:

• The PrP106-126 peptide has been instrumental in advancing prion disease research.
• Understanding of prion disease pathogenesis has evolved, incorporating oligomers and prion-like spread.
• Therapeutic strategies for prion diseases continue to develop based on these insights.